Search Medical Condition
Please enter condition
Please choose location

Leland, North Carolina Clinical Trials

A listing of Leland, North Carolina clinical trials actively recruiting patient volunteers.

RESULTS

Found (99) clinical trials

Comparative and Pragmatic Study of Golimumab Intravenous (IV) (Simponi Aria) Versus Infliximab (Remicade) in Rheumatoid Arthritis

This is a prospective, noninterventional (no treatment medication provided by the study), observational (study in which the investigators/ physicians observe the patients and measure their outcomes), multicenter (study conducted at multiple sites) study of Golimumab IV and Infliximab in RA patients. The study allows for an anticipated 2-year enrollment period ...

Phase N/A

0.0 miles

Learn More »

Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ) Compared to Placebo and Adalimumab in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease

The goal of this Phase III study is to assess the safety, tolerability, and efficacy of OKZ in subjects with moderately to severely active RA who have responded inadequately to MTX. The primary endpoint of the trial is at Week 12. Olokizumab is expected to reduce the disease activity and ...

Phase

0.0 miles

Learn More »

A research study is evaluating an investigational medication for acute migraines. This research study may be an option if you: Are at least 18 years of age Have experienced migraines for at least 1 year with onset prior to age 50 Are able to distinguish migraines from other types of ...

Phase N/A

4.77 miles

Learn More »

C. difficile (C. diff) is one of the most common causes of healthcare-related infections. C. diff is a type of bacteria that lives in the human intestines and its spores can survive outside of the body for months. These spores are resistant to cleaning and are most commonly transmitted in ...

Phase N/A

4.77 miles

Learn More »

A research study is evaluating an investigational medication for type 2 diabetes in patients who have moderate kidney impairment. The research study may be an option if you: *Have been diagnosed with type 2 diabetes *Have moderate kidney impairment *Have not taken a SGLT T-2 inhibitor (such as Forxiga® (Dapagliflozin); ...

Phase N/A

4.77 miles

Learn More »

Fluarix / FluLaval / Fluarix Quadrivalent/ FluLaval Quadrivalent Vaccine Pregnancy Registry

This study is a transition of existing ongoing pregnancy registries for Fluarix/ FluLaval/Fluarix Quadrivalent/ FluLaval Quadrivalent into one post-authorization safety study (PASS). Pregnancy outcome data will be collected using questionnaires within 3 months of the estimated date of delivery (EDD) and approximately 6 months and 12 months after the EDD ...

Phase N/A

6.6 miles

Learn More »